搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 小时
on MSN
Palo Alto Networks (PANW): Why Should You Buy This Growth Stock For The Next 5 Years?
We recently compiled a list of the 15 Best Growth Stocks to Buy for the Next 5 Years. In this article, we are going to take a ...
2 小时
Uber Technologies Inc. (UBER): Why Should You Buy This Growth Stock For The Next 5 Years?
We recently compiled a list of the 15 Best Growth Stocks to Buy for the Next 5 Years. In this article, we are going to take a ...
24/7 Wall St
1 天
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...
Cantech Letter
1 天
Is there an ETF for non dividend stocks?
There are ETFs (Exchange-Traded Funds) that focus on non-dividend stocks, although they may not specifically advertise ...
1 天
Small-cap ETFs went on a wild ride. Can they regain momentum after Trump takes office?
The sharp selloff also triggered a mass exodus from the benchmark small-cap ETF, with investors pulling more than $871 million out of IWM in the week ending Tuesday. It was also one of the three funds ...
2 天
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
Vertex Pharmaceuticals ( VRTX 3.06%) might be one of those special cases. Should you buy Vertex stock hand over fist before ...
2 天
Xenon Pharmaceuticals: 2025 Could Be Pivotal For Azetukalner's Epilepsy Potential
Xenon has promising Phase 2 data for MDD treatment, robust financials, and a potential in niche markets, despite premium ...
3 天
Sage Therapeutics: Biogen's Unsolicited Bid Is Best Step Forward For Shareholders
Sage Therapeutics' financials indicate a need for additional funding in 2025, risking dilution and further financial ...
4 天
Trade Spotlight: How should you trade Escorts Kubota, NALCO, BSE, Minda Corporation ...
The market is expected to consolidate until it gets back above all key moving averages. Below are some trading ideas for the ...
4 天
Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According ...
If we assume all patients who began treatment with Casgevy last year progress to the administration stage, CRISPR and Vertex ...
BioPharma Dive
5 天
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈